​
​

Cadrenal Therapeutics Ownership 2024 | Who Owns Cadrenal Therapeutics Now?

OverviewRevenueFinancialsChart

Institutional Ownership

0.01%

Insider Ownership

52.94%

Retail Ownership

47.05%

Institutional Holders

3.00

Cadrenal Therapeutics Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY CONCORD STREET TRUST0.00%42,6783,93310.15%Feb 29, 2024
VANGUARD INDEX FUNDS0.00%905905-Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%464--Jan 31, 2024

Cadrenal Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 42.68K shares, compromising 0.00% of its total assets.

Cadrenal Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 233-

As of 31 Mar 23, 3 institutions are holding Cadrenal Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 23847-

Cadrenal Therapeutics (CVKD) has 847.00 shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 230.01%-

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 23--

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 23--

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 233-847-0.01%-----

Cadrenal Therapeutics Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 06, 2023MURPHY JOHN RAYMONDdirector-P-PurchaseBuy2,669$0.69$1.84K614,792
Oct 06, 2023MURPHY JOHN RAYMONDdirector-P-PurchaseBuy17,331$0.70$12.13K612,123
Sep 06, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.90$17.99K3,410,000
Sep 06, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.91$18.20K3,390,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy10,000$0.84$8.43K3,370,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy10,000$0.92$9.17K3,360,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.92$18.44K3,350,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.93$18.58K3,330,000

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 06, 2023MURPHY JOHN RAYMONDdirector-P-PurchaseBuy2,669$0.69$1.84K614,792
Oct 06, 2023MURPHY JOHN RAYMONDdirector-P-PurchaseBuy17,331$0.70$12.13K612,123
Sep 06, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.90$17.99K3,410,000
Sep 06, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.91$18.20K3,390,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy10,000$0.84$8.43K3,370,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy10,000$0.92$9.17K3,360,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.92$18.44K3,350,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.93$18.58K3,330,000

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 10, 2024Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanG-GiftSell50,000--3,275,000
Apr 03, 2024Cole Jeffrey Scottofficer Chief Operating OfficerSell50,000$0.64$32.00K-
Apr 03, 2024Cole Jeffrey Scottofficer Chief Operating OfficerSell150,000$0.94$141.00K-
Feb 12, 2024Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanG-GiftSell85,000--3,325,000

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 10, 2024Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanG-GiftSell50,000--3,275,000
Apr 03, 2024Cole Jeffrey Scottofficer Chief Operating OfficerA-AwardBuy150,000$0.62$93.00K150,000
Apr 03, 2024Cole Jeffrey Scottofficer Chief Operating OfficerSell50,000$0.64$32.00K-
Apr 03, 2024Cole Jeffrey Scottofficer Chief Operating OfficerSell150,000$0.94$141.00K-
Feb 12, 2024Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanG-GiftSell85,000--3,325,000
Jan 19, 2024Zelenkofske Stevendirector-A-AwardBuy100,000$0.94$94.00K100,000
Jan 19, 2024MURPHY JOHN RAYMONDdirector-A-AwardBuy100,000$0.94$94.00K100,000
Jan 19, 2024Lisicki Robertdirector-A-AwardBuy50,000$0.94$47.00K50,000
Jan 19, 2024Pham Quang Xdirector, 10 percent owner, officer Chief Executive OfficerA-AwardBuy150,000$0.94$141.00K150,000
Jan 19, 2024Szot Matthew Kofficer Chief Financial OfficerA-AwardBuy250,000$0.94$235.00K250,000
Jan 19, 2024WILSON GLYNNdirector-A-AwardBuy70,000$0.94$65.80K70,000
Jan 19, 2024LOSORDO DOUGLAS Wofficer Chief Medical OfficerA-AwardBuy150,000$0.94$141.00K150,000
Oct 06, 2023MURPHY JOHN RAYMONDdirector-P-PurchaseBuy2,669$0.69$1.84K614,792
Oct 06, 2023MURPHY JOHN RAYMONDdirector-P-PurchaseBuy17,331$0.70$12.13K612,123
Sep 06, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.90$17.99K3,410,000
Sep 06, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.91$18.20K3,390,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy10,000$0.84$8.43K3,370,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy10,000$0.92$9.17K3,360,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.92$18.44K3,350,000
Sep 05, 2023Pham Quang Xdirector, 10 percent owner, officer CEO and ChairmanP-PurchaseBuy20,000$0.93$18.58K3,330,000

The last insider sell of Cadrenal Therapeutics's stock was made by Pham Quang X on Apr 10 2024, selling 50,000 shares at - per share (valued at -). The last insider buy of CVKD was made by MURPHY JOHN RAYMOND on Oct 06 2023, buying 2,669 shares at $0.69 per share (worth $1.84K).

Cadrenal Therapeutics Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2025-1-
Q2 202411100.00%
Q1 20247--
Q4 202321200.00%
Q3 202382400.00%
Q1 20235862.50%
Q4 2022-1-
Q3 2022-1-

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Cadrenal Therapeutics's insiders, as of Q1 2025.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2025---
Q2 2024---
Q1 2024---
Q4 20232--
Q3 20237--
Q1 20231--
Q4 2022---
Q3 2022---

As of Q1 2025, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cadrenal Therapeutics's stocks.

Cadrenal Therapeutics Peer Ownership

TickerCompany
SNTISenti Biosciences, Inc.
ENOBRenovaro Biosciences Inc.
PMVPPMV Pharmaceuticals, Inc.
MNPRMonopar Therapeutics Inc.
CNTACentessa Pharmaceuticals plc
IKNAIkena Oncology, Inc.
IKTInhibikase Therapeutics, Inc.
XCURExicure, Inc.
FHTXFoghorn Therapeutics Inc.
MLYSMineralys Therapeutics, Inc.
SABSSAB Biotherapeutics, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
ANTXAN2 Therapeutics, Inc.
HCWBHCW Biologics Inc.
GPCRStructure Therapeutics Inc.
ANEBAnebulo Pharmaceuticals, Inc.
NVCTNuvectis Pharma, Inc.
ELYMEliem Therapeutics, Inc.

CVKD Ownership FAQ

Cadrenal Therapeutics is owned by institutional shareholders (0.01%), insiders (52.94%), and public (47.05%). The largest institutional shareholder of Cadrenal Therapeutics is (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

As of Mar 2023, there are 3 institutional shareholders of Cadrenal Therapeutics.